首页> 外国专利> Enhanced autologous growth factor production and delivery system

Enhanced autologous growth factor production and delivery system

机译:增强的自体生长因子生产和输送系统

摘要

Systems and methods for producing enhanced blood serum with concentrated growth factors and/or prophylactically and therapeutically active proteins. An autologous blood product is obtained from a donor and then incubated into a containment device (sterile container) that includes a source of cells or tissue (for example, autologous, allogeneic, or xenographic tissue, or combinations thereof). The cells from the injected fluid (autologous blood product) interact/incubate with the source of cells or tissue inside the containment device, to produce a serum that is loaded with autologous proteins, growth factors, and cytokines. The autologous blood product may be a fluid and/or composition that includes blood, whole blood, autologous conditioned plasma, platelet-rich plasma, platelet-poor plasma, bone marrow aspirate, bone marrow concentrate and stem cells, among others, and combinations thereof.
机译:用于产生具有浓缩的生长因子和/或预防和治疗活性蛋白的增强血清的系统和方法。从供体获得自体血液产品,然后温育到包含细胞或组织(例如,自体,异体或异种组织或其组合)来源的容纳装置(无菌容器)中。来自注射液(自体血液制品)的细胞与安全壳装置内的细胞或组织来源相互作用/孵育,以产生一种载有自体蛋白质,生长因子和细胞因子的血清。自体血液产品可以是流体和/或组合物,其包括血液,全血,自体条件性血浆,富血小板血浆,贫血小板血浆,骨髓抽吸液,骨髓浓缩液和干细胞等,及其组合。 。

著录项

  • 公开/公告号US9205110B2

    专利类型

  • 公开/公告日2015-12-08

    原文格式PDF

  • 申请/专利权人 ARTHREX INC.;

    申请/专利号US201313941899

  • 发明设计人 CHRISTOPHER M. BARE;

    申请日2013-07-15

  • 分类号A01N1/02;C12N5;C12N5/02;A61K35/16;A61K35/12;

  • 国家 US

  • 入库时间 2022-08-21 14:27:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号